2020
DOI: 10.1038/s41419-020-03275-2
|View full text |Cite
|
Sign up to set email alerts
|

Distinct photo-oxidation-induced cell death pathways lead to selective killing of human breast cancer cells

Abstract: Lack of effective treatments for aggressive breast cancer is still a major global health problem. We have previously reported that photodynamic therapy using methylene blue as photosensitizer (MB-PDT) massively kills metastatic human breast cancer, marginally affecting healthy cells. In this study, we aimed to unveil the molecular mechanisms behind MB-PDT effectiveness and specificity towards tumor cells. Through lipidomics and biochemical approaches, we demonstrated that MB-PDT efficiency and specificity rely… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
27
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(29 citation statements)
references
References 55 publications
1
27
0
Order By: Relevance
“…4 ). In agreement with the low sensitivity of non-tumorigenic MCF-10A cells to PDT with Alectinib shown here, a recent study has shown that non-tumorigenic human breast cells also are more resistant to PDT using methylene blue as photosensitizer (MB-PDT), whereas very aggressive triple-negative breast cancer cells (TNBCs) displayed high susceptibility to MB-PDT induced cell death [ 11 ]. Upon photooxidation MB disrupts lysosome integrity and induces lysosomal membrane permeabilization (LMP), which is accompanied by necroptosis or both necroptosis and ferroptosis in non-invasive and highly aggressive tumor cells, respectively.…”
Section: Discussionsupporting
confidence: 83%
See 2 more Smart Citations
“…4 ). In agreement with the low sensitivity of non-tumorigenic MCF-10A cells to PDT with Alectinib shown here, a recent study has shown that non-tumorigenic human breast cells also are more resistant to PDT using methylene blue as photosensitizer (MB-PDT), whereas very aggressive triple-negative breast cancer cells (TNBCs) displayed high susceptibility to MB-PDT induced cell death [ 11 ]. Upon photooxidation MB disrupts lysosome integrity and induces lysosomal membrane permeabilization (LMP), which is accompanied by necroptosis or both necroptosis and ferroptosis in non-invasive and highly aggressive tumor cells, respectively.…”
Section: Discussionsupporting
confidence: 83%
“…There were no significant differences between any of the exposure times. Recently, it has shown that the triple-negative breast cancer cells MDA-MB-231 display a high susceptibility to PDT [ 11 ]. Since we want to compare the MDA-MB-231 cells with other cell lines which might be less susceptible an exposure time of 60 min was chosen for further experiments.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Induction of mixed cell death types has also been shown in another approach based on PDT and methylene blue [ 174 , 175 ]. This approach was effective against highly aggressive triple-negative breast cancer MDA-MB-231 cells; it induced lysosomal membrane permeabilization, which led to ferroptosis and necroptosis.…”
Section: Ferroptosismentioning
confidence: 99%
“…221 Singlet oxygen reacts with adjacent biological macromolecules to induce cytotoxicity, which leads to cell damage and even death. 222 In the treatment of oesophageal cancer, 223 lung cancer, 224 skin cancer, 225 breast cancer 226 and other diseases, PDT is a new tumour treatment technology that has risen and developed in recent years. As a cold photochemical reaction, the basic elements of PDT are oxygen, photosensitizer and visible light (commonly applied with a laser).…”
Section: Photodynamic Therapymentioning
confidence: 99%